Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 146 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company 5Metis Inc. | Activity: Research and Development | Company Description 5Metis creates new active ingredients, products, and manufacturing processes for the crop protection industry. | Location Durham |
| |
Company Advanced Animal Diagnostics Inc. | Activity: Research and Development | Company Description Advanced Animal Diagnostics (AAD) develops and commercializes diagnostics to detect and manage disease states, reproductive, nutritional and overall health status of production animals. | Location Morrisville |
| |
Company AgBiome Inc. | Activity: Research and Development | Company Description AgBiome uses its proprietary GENESIS™ platform to capture diverse, unique microbes for agriculturally relevant applications, and screens them with industry-best assays for insect, disease, and nematode control. AgBiome also develops and sells crop protection solutions. | Location Research Triangle Park |
| |
Company Algaen Corp. | Activity: Research and Development | Company Description Algaen uses microalgae to develop, produce and market products and technologies for the nutraceutical, pharmaceutical and bio-energy industries. | Location Winston-Salem |
| |
Company Altis BioSystems Inc. | Activity: Research and Development | Company Description Altis Biosystems has developed a patented stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. | Location Durham |
| |
Company Aniluxx Biotechnology Inc. | Activity: Research and Development | Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. | Location Chapel Hill |
| |
Company Animal Cancer Dx | Activity: Research and Development | Company Description Animal Cancer Dx is a chemical and biomolecular diagnostic company developing technology for the early detection of cancer in dogs. | Location Raleigh |
| |
Company Arbiom Inc. | Activity: Research and Development | Company Description Arbiom develops technologies that convert residues from agriculture and forestry into a high-protein ingredient for aquaculture and animal feed. The Raleigh office is Arbiom's application center. | Location Durham |
| |
Company Artizan Biosciences Inc. | Activity: Research and Development | Company Description Artizan is developing a platform for identifying and targeting pathogenic intestinal bacteria, with a focus on inflammatory bowel disease and potential applications in autoimmune diseases, obesity, skin, lung and central nervous system diseases. | Location Durham |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Atsena Therapeutics Inc. | Activity: Research and Development | Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. | Location Durham |
| |
Company BASF Agricultural Solutions | Activity: Research and Development | Company Description BASF's Agricultural Solutions division conducts seeds, traits and plant biotechnology research with a focus on yield and quality traits in major crops. Its RTP campus also houses a bee care center. | Location Research Triangle Park |
| |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. | Location Morrisville |
| |
Company Bayer Environmental Science | Activity: Research and Development | Company Description Bayer Environmental Science develops and markets pest-, weed- and disease-control products for non-agricultural areas such as vector control, professional pest management, industrial vegetation management, forestry and turf and ornamentals. | Location Cary |
| |
Company Bedrock Therapeutics Inc. | Activity: Research and Development | Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. | Location Raleigh |
| |
Company BENANOVA Inc. | Activity: Research and Development | Company Description BENANOVA develops antimicrobial nanotechnology products for the disinfectant, cosmetic and agricultural industries. | Location Raleigh |
| |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Biofidelity Inc. | Activity: Research and Development | Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. | Location Morrisville |
| |
Company BioResource International Inc. | Activity: Research and Development | Company Description BioResource International (BRI) designs, develops and manufactures unique enzymes that help poultry and swine producers optimize animal nutrition and gut health. | Location Durham |
| |
Company Biorg Inc. | Activity: Research and Development | Company Description Biorg is developing and commercializing organoid technology for use in life science applications such as diagnostics, drug screenings and toxicology. | Location Winston-Salem |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company Blue Ridge Bantam | Activity: Research and Development | Company Description Blue Ridge Bantam is developing cell-based turkey meat using tissue engineering. | Location Durham |
| |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh |
| |
Company Brightseed (Durham) | Activity: Research and Development | Company Description Brightseed developed an AI-driven discovery platform, Forager, to identify plant bioactives as potential therapeutic solutions. | Location Durham |
| |
Company Celldom Inc. | Activity: Research and Development | Company Description Celldom is developing next generation, high throughput single cell analysis technology with applications in research, drug discovery and drug development. Its technology enables the investigation of diversity in large cell populations. | Location Durham |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Research Triangle Park |
| |
Company Cereius Inc. | Activity: Research and Development | Company Description Cereius is developing novel radio-labeled therapeutics for treating solid tumor brain metastasis. | Location Durham |
| |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham |
| |
Company Cotton Incorporated | Activity: Research and Development | Company Description Cotton Incorporated's Agricultural & Environmental Research Division improves cotton cultivation through genetic and biotechnology tools, enhancing yield, quality and resistance of cotton varieties. | Location Cary |
| |
Company Couragen Biopharmaceutics LLC | Activity: Research and Development | Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. | Location Chapel Hill |
| |
Company Crop Microclimate Management Inc. | Activity: Research and Development | Company Description Crop Microclimate Management researches and develops technologies to improve crop productivity by mitigating the impact of environmental stresses. | Location Wilmington |
| |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham |
| |
Company Data Driven Bioscience Inc. | Activity: Research and Development | Company Description Data Driven Bioscience uses genomic tests, datasets and machine learning solutions to enable hospitals and pharmaceutical companies to diagnose cancer and personalize cancer treatment. | Location Durham |
| |
Company Denizen Biologics LLC | Activity: Research and Development | Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. | Location Cary |
| |
Company Dualogics LLC | Activity: Research and Development | Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. | Location Durham |
| |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham |
| |
Company Elo Life Systems Inc. | Activity: Research and Development | Company Description Elo Life Systems uses a platform of precision breeding technologies to produce crops with novel traits. | Location Durham |
| |
Company EnviroFlight LLC | Activity: Research and Development | Company Description EnviroFlight provides dried black soldier fly larvae products as a source of sustainable alternative protein. | Location Apex |
| |
Company Enzerna Biosciences Inc. | Activity: Research and Development | Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. | Location Morrisville |
| |
Company Enzyvant Inc. (Cary) | Activity: Research and Development | Company Description Enzyvant, a subsidiary of Sumitovant Biopharma, develops regenerative therapeutics for rare diseases such as congenital athymia. The Cary location is their headquarters. | Location Cary |
| |
Company EpiCypher Inc. | Activity: Research and Development | Company Description EpiCypher develops and manufactures novel products and services for epigenetics and chromatin biology, focused on enabling drug discovery research and development. | Location Durham |
| |
Company Epigenos Biosciences Inc. | Activity: Research and Development | Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation. | Location Morrisville |
| |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte |
| |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh |
| |
Company GENIE Therapeutics | Activity: Research and Development | Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. | Location Winston-Salem |